|
HS Code |
571030 |
| Cas Number | 4653-34-1 |
| Molecular Formula | C6H12N2O |
| Molecular Weight | 128.17 g/mol |
| Iupac Name | 1-acetylpiperazine |
| Synonyms | N-Acetylpiperazine |
| Appearance | Colorless to pale yellow liquid |
| Boiling Point | 265-267 °C |
| Melting Point | -2 °C |
| Density | 1.07 g/cm3 |
| Solubility In Water | Miscible |
| Flash Point | 132.7 °C |
| Purity | Typically >98% |
| Smiles | CC(=O)N1CCNCC1 |
As an accredited 1-Acetylpiperazine factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | 1-Acetylpiperazine is supplied in a 500g amber glass bottle, featuring a tamper-evident cap and a clear hazard label. |
| Shipping | **1-Acetylpiperazine** is shipped in tightly sealed, chemical-resistant containers to prevent leakage and contamination. It is transported according to relevant safety regulations, protected from light, heat, and moisture. Proper labeling and documentation are included to ensure safe handling. Shipping must comply with local and international hazardous materials guidelines. |
| Storage | 1-Acetylpiperazine should be stored in a tightly closed container in a cool, dry, and well-ventilated area away from incompatible substances such as strong oxidizers and acids. It should be kept out of direct sunlight and away from heat sources. Use appropriate personal protective equipment when handling, and ensure proper labeling and secure storage to prevent accidental exposure or spillage. |
Applications of 1-Acetylpiperazine in Industrial Manufacturing1-Acetylpiperazine functions as a key intermediate in several advanced industrial production chains. As the original manufacturer, we deliver consistent quality tailored to specification requirements for high-value downstream sectors. The following sections detail specialty industrial applications, integration parameters, compliance obligations, process positioning, and end-use product forms. 1. Pharmaceutical Intermediate for Anticancer and CNS APIsPharmaceutical synthesis often utilizes 1-Acetylpiperazine in the multi-step preparation of active pharmaceutical ingredients targeting central nervous system disorders and selected oncology therapies. Leading API manufacturers incorporate this intermediate for constructing heterocyclic scaffolds required by specific small-molecule drugs. Application steps cover acylation, substitution, and N-alkylation, demanding strict traceability and purity control at each stage of process validation. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Agrochemical Intermediate for Fungicides and Plant Growth RegulatorsMajor agrochemical producers depend on 1-Acetylpiperazine for manufacturing active compounds present in fungicidal and plant growth regulating formulations. Its use facilitates construction of nitrogen-rich moieties crucial to bioactivity, particularly in protecting cereal crops and vegetables from fungal pathogens. Strict batch control secures product traceability during intermediate handover and downstream formulation. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. API Intermediate for Anthelmintics and Veterinary DrugsAnimal health companies utilize 1-Acetylpiperazine in the regulated production of anthelmintic agents for livestock and companion animals, especially those targeting nematode infestations. Manufacturers introduce this intermediate for constructing azine structures that define the efficacy and selectivity profiles of market-approved veterinary drugs, implementing validated synthetic protocols. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Chemical Synthesis Intermediate for Polymeric Resin AdditivesPolymer additive manufacturers incorporate 1-Acetylpiperazine during production of specialized modifiers and curing agents for epoxy and polyurethane resins. Its introduction modifies chain flexibility and impacts crosslink density, influencing downstream mechanical and thermal properties of advanced polymer matrices. Formulators carefully balance dosing to achieve targeted resin performance in automotive, electronics, and marine coatings applications. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
5. Specialty Solvent Component in High-Performance Electrolyte BlendsBattery material and specialty electrolyte producers integrate 1-Acetylpiperazine as a cosolvent or stabilizer in nonaqueous electrolyte blends, supporting advanced lithium-ion and sodium-ion cell R&D. The N-acetyl structure contributes to solvating capabilities and stabilizes electrochemical interface layers in prototype formulations. Selection and ratio depend on rigorous bench-scale and pilot validation under simulated field cycling. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive 1-Acetylpiperazine prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Every day on the production line, I see the distinct role of 1-Acetylpiperazine unfolding – a white crystalline solid with the chemical formula C6H12N2O, emerging from the reactors with a steady, reliable yield. This compound carries a CAS number of 120-88-9. In our facility, we produce it both for our own projects and for clients across multiple sectors. Direct engagement with the synthesis process sharpens our respect for how this intermediate brings efficiency and reliability into pharmaceutical and specialty chemical development.
The typical purity of our 1-Acetylpiperazine runs at or above 99.0% by HPLC. Moisture content lands well below 0.5%, confirmed by Karl Fischer titration. We measure melting point consistently between 52 and 56°C. Though some might gloss over these numbers, for anyone hands-on in the lab or managing a downstream process, these concrete details make or break a reaction – particularly in the preparation of active pharmaceutical ingredients, where trace impurities or too much water can destroy yields and run afoul of regulatory standards.
Packaging in our site uses sealed, double-layer drums to protect that purity during both storage and transit. Each batch is barcoded and tied to a full analytical profile, not to fill in a spreadsheet, but because these lot records have pulled us out of near-misses more than once during an audit or troubleshooting session.
Pharma companies come to us for 1-Acetylpiperazine as a critical intermediate for antihistamine, anticancer, and antipsychotic compounds. We’ve supported teams working on both generics and novel entities. Almost every batch leaves our loading dock with an origin destined for further transformation, whether it’s N-deacetylation to make piperazine or use in the acylation steps leading up to more complex heterocycles.
Chemical research organizations have built on our product for method development, often feeding back new purification tricks or reaction conditions that make our next campaigns smoother and more scalable. Contract manufacturers report consistent crystallization results when running gram to pilot-scale synthesis, a testament to both the compound’s reactivity and the attention we put into particle size and dryness.
Manufacturing 1-Acetylpiperazine may look simple in a textbook, but the plant-scale process has its quirks. Acetylation of piperazine uses acetic anhydride under strictly controlled temperature and agitation – with pH continuously monitored to prevent side reactions. We’ve experimented with various purification paths, but direct crystallization from methanol offers the cleanest outcome, provided the incoming piperazine feedstock meets the right quality. Achieving consistent throughput without process hiccups depends as much on raw materials as on the vigilance of trained technicians following a strict batch protocol.
Controlling impurities teaches the most. Impurities such as N,N’-diacetylpiperazine or unreacted starting material show up in trace amounts. We analyze every batch by both GC-MS and HPLC, not only for GMP requirements – decades of experience have shown even small deviations can multiply issues in the downstream active pharmaceutical ingredient steps. Whenever feedback returns about a color change or unexpected melting point shift, we track it back to these subtle factors.
Our product exits the dryers as a fine, white powder with a slight crystalline sheen. It flows easily but does not form dust clouds easily, something appreciated by technicians measuring out material in confined spaces. Some intermediates give off pungent or noxious odors, but this one leaves only a mild acetic scent, sparing everyone from headaches and making it manageable in regular fume hoods.
Long-term storage at room temperature keeps 1-Acetylpiperazine stable for over two years, as confirmed by our internal studies. Nothing erodes confidence on the customer side like finding clumps, yellowing, or off-odors after only a few months. It’s a small but crucial reason why end users stay with manufacturers that sweat the details and continually sample their own product for stability trends.
There’s sometimes a temptation among buyers to look only at price or to grab from whatever source shows up in a binder. Years of fielding technical service calls have shown us the hidden costs of inconsistent supply. If material comes from a facility without strict in-process controls, downstream users quickly see unpredictable crystallization behavior or need to deal with unfiltered particles. For some customers, an extra filtration step adds hours; for others, it means a fully rejected batch. All this comes back to the manufacturer’s standards.
As direct producers, we keep our quality transparent. Each drum can be traced back to a particular line and shift. If a customer points out an unexpected result in their own testing, we swap samples and walk through both sets of data. This openness cuts through a lot of self-inflicted headaches when compared to buying from unknown brokers or loose-chain resellers.
1-Acetylpiperazine has structural relatives: plain piperazine, N,N’-diacetylpiperazine, unsubstituted cyclic diamines. Some firms ask if they can substitute one for another to cut costs, but our experience says the chemical differences aren’t trivial. The acetyl group in 1-Acetylpiperazine tempers nucleophilicity without blocking the entire ring. This lets it function as a solid intermediate for reactions demanding selectivity and prevents side reactions from derailing the synthesis of secondary and tertiary amines.
We’ve seen substituting with fully acetylated or unacetylated piperazine often drives up the need for purification or creates downstream by-products tricky to remove. Every time the reaction profile shifts, teams can lose time and expensive starting materials before tracking down a seemingly minor substitution at the start of the synthesis. For those aiming for compliance in regulated pharma space, such unplanned changes complicate documentation and risk audits. It rarely pays off in cost or compliance.
Listening to our partners has sharpened our production. One pharmaceutical client running a two-step amination found our controlled particle size distribution trimmed their filtration time by 15% compared to alternatives from less consistent sources. Contract research firms often communicate minor lot-to-lot variations, which we take directly into our batch adjustment protocol.
Problems can arise if a downstream acylation or condensation reaction encounters excess moisture or impurities, leading to brownish discoloration or reduced crystal formation. Our laboratory tracks out-of-trend shifts, working backward from any user complaints to the exact raw material, cleaning, or process tweak. Keeping open communication with formulators and process engineers worldwide continues to strengthen both our process and our product.
Custom synthesis demands adaptable intermediates, and 1-Acetylpiperazine proves its worth time and again. Clients in the agrochemical sector use it to fine-tune the introduction of functional amine groups in pesticide molecules, capitalizing on its selective reactivity. Small-molecule pharma innovators integrate it as a masked amine in their libraries, bypassing side reactions that plain piperazine can trigger under more basic or acidic conditions.
Our technical team holds regular roundtables with clients, sharing insights into how minor process tweaks—like a specifically timed acetylation or optimized batch size—can trim costs, reduce waste, and avoid regulatory headaches. These exchanges go far beyond generic specification sheets: they recognize how every user adapts the intermediate in a slightly different context, whether in a kilo lab or a multi-ton facility.
Pharmaceutical-quality intermediates like 1-Acetylpiperazine require robust documentation and traceability. All our batches come with full impurity data, residual solvent analysis, and a certificate of analysis prepared by actual site chemists. Auditors and regulatory inspectors walk our lines yearly, reviewing these records as part of our compliance strategy. Many customers ask for occasional samples from previous batches, and having data that stretches back years gives them both reassurance and a real compliance advantage.
Our supply chain team invests extra effort in qualifying incoming piperazine and acetic anhydride from approved vendors. If upstream materials drift out of spec – on purity, color, or water content – downstream effects cascade fast. One misstep can end up costing weeks in repeated analysis, extra purification, or even product recalls. Operators on the plant floor play a key role here, catching off-notes or subtle appearance changes that don’t show in paperwork alone.
Producing organonitrogen intermediates like 1-Acetylpiperazine brings its own safety profile. Our team built out reaction vessels with local venting, double seal gaskets, and continuous pH feedback loops years before some of these features became standard. Not only does this protect our crew, but it also keeps batch-to-batch consistency tighter. The process generates minimal waste, which we neutralize and send as safe salts for chemical recycling. By designing the acetylation with efficient heat and product recovery, we have lowered solvent use year over year and knocked down our energy costs.
Even seasoned operators look for ways to cut waste in cleanout and material transfer steps. All washings and rinse water are tested before discharge, matching local regulatory requirements and eliminating cross-contamination risks for the next batch. Our direct feedback loop from production to environmental management constantly surfaces ideas from the workforce, driving ongoing improvements in sustainability and safety.
Disruptions in chemical supply chains hit hardest during surges in demand, regulatory changes, or plant outages. We receive regular inquiries from teams burned by erratic deliveries or product that fails mid-process. Knowing we produce our 1-Acetylpiperazine on-site brings peace of mind to partners; they do not have to worry about product switching hands through a maze of brokers, risking adulteration, commingling, or origin confusion.
For global clients facing customs documentation, robust batch records streamline import approval and maintain continuity in regulated manufacturing. Our product leaves with documents signed by the personnel who actually ran the process, not generic templates filled after the fact. Consistent, documented processes matter most for pharmaceutical and high-spec fine chemical users, who stand to lose the most from off-spec runs or incomplete traceability.
Fielding customer concerns about reaction weirdness, off-odors, or batch-to-batch differences brings valuable insight. A few years ago, a biopharma customer flagged a recurring problem with solubility. Collaborating over several batches, we isolated the culprit: not the 1-Acetylpiperazine itself, but a solvent lot that carried hidden contaminants into their system. Troubleshooting rooted in direct dialogue, sample sharing, and willingness to inspect both sides makes for major time savings on both ends.
We rely on our application support chemists, who have spent years on both the supplier and the customer side, to bridge this gap. They walk through the customer’s reaction scheme, examine raw data, and suggest process fixes, sometimes as simple as pre-heating or shifting crystallization temperatures. Avoiding boilerplate, one-size-fits-all advice allows teams to lock in gains on yield, purity, and cost.
Each new campaign provides lessons. If new analytical data or feedback signals a shift in impurity profile, we adapt – switching solvents or tweaking filtration steps. Process R&D here does not happen in isolation; it flows from input received in process validation, scale-up runs, and direct conversations with the end user’s own chemists.
In particular, as environmental limits tighten and buyers push for green chemistry, our process teams have piloted alternate reagents and solvent recovery systems. Reducing the use of chlorinated solvents and adopting more energy-efficient crystallization steps helped us cut both operating costs and environmental footprint. These innovations aren’t theoretical—they arrive on the plant floor and become standard only with direct input from shop floor experience and client needs.
For bench chemists and plant engineers, the usability of 1-Acetylpiperazine shows in handling, reaction setup, and downstream workup. Its free-flowing nature lets users weigh, dissolve, and transfer material easily, while the minimal odor and dusting support safer day-to-day work. Fewer headaches from caking or powdering translate to improved batch reproducibility, giving users more time for higher-value work instead of troubleshooting stuck lines or incomplete dissolutions.
Batch uniformity arises from meticulous drying, sieving, and packaging, not from wishful thinking. Every operator and supervisor here knows how easily a rushed wash or a misstep in drying can carry through to customer complaints or rejected shipments. Because we only move finished goods after internal and customer-driven tests confirm quality, end users consistently tell us they see fewer surprises – saving them both immediate rework and future regulatory trouble.
In the larger context of fine and specialty chemicals, 1-Acetylpiperazine holds its ground as a workhorse intermediate. Its appeal lies in balanced reactivity, reliable physical properties, and real-world adaptability that keeps pace with evolving laboratory and process needs. By owning the full production span—from raw material intake, through reaction, purification, analysis, and packaging—we ensure our partners can trust the foundation of their own chemistry, whether in regulated pharma, research, or new materials development.
Our commitment turns on direct, hands-on knowledge, constant iteration, and open channels with the technical community. Experience has taught us that real value in a chemical intermediate comes not just from spec sheets but from practical reliability and adaptation to every next challenge. With new regulations, applications, and customer goals continually reshaping the field, those strengths remain more important than any single number or batch result. 1-Acetylpiperazine keeps earning its place not by resting on old standards, but by proving itself every day at the bench and in the reactor.